News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eli Lilly and Company (LLY) to Raise Nearly $750 Million to Share Drug Development Costs



2/14/2011 8:20:56 AM

PBR -- Eli Lilly intends to raise nearly $750m through three funds to share drug development costs and potential benefits, as part of its plans to find new ways to improve the high failure rates and costs of drugs as generic competition with pricing pressures threatening its existing products.



comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES